Rx (Prescription Medicine)
USD $ 45.00
Pangraf 0.5mg Capsule 是一种关键药物，主要用于防止器官移植患者的器官排斥。其活性成分 Tacrolimus 是一种磷酸二酯酶抑制剂，属于免疫抑制剂。Tacrolimus 通过抑制免疫系统的活性，从而降低机体排斥移植器官的可能性。这对器官移植的长期成功至关重要，使患者能够过上更健康的生活。
Pangraf 0.5mg Capsule 的适应症包括在成人器官移植患者中预防器官排斥，常用于肾脏、肝脏或心脏移植。它通常与其他免疫抑制剂联合使用。
剂量应严格由合格的医疗专业人员根据个体患者的情况、移植类型以及治疗反应确定。通常每天口服两次。为维持血药浓度稳定，应每天在相同时间服用 Pangraf 0.5mg Capsule。
常见不良反应可能包括震颤、腹泻、恶心、肾功能问题、高血压和血糖升高。如出现任何不寻常或严重的不良反应，患者应立即向医生报告。治疗期间定期监测血药浓度和肾功能是必不可少的。
Pangraf 0.5mg Capsule 应储存在室温，避免潮湿和热源。请放在儿童不易触及的地方。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Brand Name | |
| Pack Quantity | |
| Strength |
其他品牌的 Tacrolimus 0.5 mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
